These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15592671)

  • 21. All-transretinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia.
    Al Bahar S; Pandita R; Bavishi K; Kreze O
    Indian J Cancer; 2004; 41(3):125-8. PubMed ID: 15472411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A survival study and prognostic factors analysis on acute promyelocytic leukemia at a single center.
    Xin L; Wan-jun S; Zeng-jun L; Yao-zhong Z; Yun-tao L; Yan L; Chang-chun W; Qiao-chuan L; Ren-chi Y; Ming-zhe H; Jian-xiang W; Lu-gui Q
    Leuk Res; 2007 Jun; 31(6):765-71. PubMed ID: 17007927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients.
    Dai CW; Zhang GS; Shen JK; Zheng WL; Pei MF; Xu YX; Cao YX; Yi Y; Yang JJ; Peng HL; Zhong HY; Li RJ
    Acta Haematol; 2009; 121(1):1-8. PubMed ID: 19246888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A non-classical translocation involving 17q12 (retinoic acid receptor alpha) in acute promyelocytic leukemia (APML) with atypical features.
    Corey SJ; Locker J; Oliveri DR; Shekhter-Levin S; Redner RL; Penchansky L; Gollin SM
    Leukemia; 1994 Aug; 8(8):1350-3. PubMed ID: 8057672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term remission after first-line single-agent treatment with arsenic trioxide of relapsed acute promyelocytic leukemia in an 8-year-old boy.
    Ebinger M; Schwarze CP; Feuchtinger T; Scheel-Walter HG; Lang P; Hildenbrand S; Gessler P; Handgretinger R
    Pediatr Hematol Oncol; 2011 May; 28(4):334-7. PubMed ID: 21345080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia].
    Xu XJ; Shi SW; Tang YM; Song H; Yang SL; Wei J; Xu WQ; Pan BH; Chen YH; Zhao FY; Shen HQ; Qian BQ; Zhang LY; Ning BT
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):28-33. PubMed ID: 17306073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination brings long-term remission in acute promyelocytic leukemia refractory for both all-trans retinoic acid and arsenic trioxide.
    Sasaki M; Sugimoto K; Isobe Y; Oshimi K
    Eur J Haematol; 2008 Aug; 81(2):160. PubMed ID: 18363868
    [No Abstract]   [Full Text] [Related]  

  • 28. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
    Rizzatti EG; Portieres FL; Martins SL; Rego EM; Zago MA; Falcão RP
    Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained molecular remission in advanced acute promyelocytic leukemia with combined pulsed retinoic acid and arsenic trioxide. Clinical evidence of synergistic effect and real-time quantification of minimal residual disease.
    Visani G; Piccaluga PP; Martinelli G; Rossi M; Malagola M; Baccarani M
    Haematologica; 2003 Apr; 88(4):ELT15. PubMed ID: 12681992
    [No Abstract]   [Full Text] [Related]  

  • 30. PHA-Induced Peripheral Blood Cytogenetics and Molecular Analysis: a Valid Diagnostic and Follow-up Modality for Acute Promyelocytic Leukemia Patients Treated with ATRA and/or Arsenic Tri-oxide.
    Baba SM; Azad NA; Shah ZA; Afroze D; Pandith AA; Jan A; Aziz SA; Dar FA
    Asian Pac J Cancer Prev; 2016; 17(4):1999-2006. PubMed ID: 27221887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of children with newly diagnosed acute promyelocytic leukemia with arsenic trioxide: a single center experience.
    George B; Mathews V; Poonkuzhali B; Shaji RV; Srivastava A; Chandy M
    Leukemia; 2004 Oct; 18(10):1587-90. PubMed ID: 15356649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What is the role of arsenic in newly diagnosed APL?
    Tallman MS
    Best Pract Res Clin Haematol; 2008 Dec; 21(4):659-66. PubMed ID: 19041605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two new molecular PML-RARalpha variants: implications for the molecular diagnosis of APL.
    Vizmanos JL; Larrráyoz MJ; Odero MD; Lasa R; González M; Novo FJ; Calasanz MJ
    Haematologica; 2002 Aug; 87(8):ELT37. PubMed ID: 12161382
    [No Abstract]   [Full Text] [Related]  

  • 34. Prolonged molecular remission in PML-RARalpha-positive acute promyelocytic leukemia treated with minimal chemotherapy followed by maintenance including the histone deacetylase inhibitor sodium valproate.
    McMullin MF; Nugent E; Thompson A; Hull D; Jones FG; Grimwade D
    Leukemia; 2005 Sep; 19(9):1676-7. PubMed ID: 16034463
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapy of molecular relapse in acute promyelocytic leukemia.
    Lo Coco F; Diverio D; Avvisati G; Petti MC; Meloni G; Pogliani EM; Biondi A; Rossi G; Carlo-Stella C; Selleri C; Martino B; Specchia G; Mandelli F
    Blood; 1999 Oct; 94(7):2225-9. PubMed ID: 10498592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late relapse of acute promyelocytic leukemia treated with all- trans retinoic acid and chemotherapy: report of two cases.
    Ferrara F; Selleri C; Mele G; Serio B; Palmieri S; Pocali B; Pane F; Rotoli B
    Ann Hematol; 2004 Jul; 83(7):484-6. PubMed ID: 14730393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reinduction of relapsed acute promyelocytic leukemia with ATRA and low dose antimetabolite-based chemotherapy.
    Dvorak CC; Sanders RP; Dahl GV; Donaldson SS; Razzouk BI
    Pediatr Blood Cancer; 2007 May; 48(5):582-5. PubMed ID: 16123994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can we say farewell to monitoring minimal residual disease in acute promyelocytic leukaemia?
    Grimwade D; Jovanovic JV; Hills RK
    Best Pract Res Clin Haematol; 2014 Mar; 27(1):53-61. PubMed ID: 24907017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The significance of minimal residual disease kinetics in adults with newly diagnosed PML-RARalpha-positive acute promyelocytic leukemia: results of a prospective trial.
    Lee S; Kim YJ; Eom KS; Min CK; Kim HJ; Cho SG; Lee JW; Min WS; Kim CC
    Haematologica; 2006 May; 91(5):671-4. PubMed ID: 16627255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL).
    Gupta V; Yi QL; Brandwein J; Lipton JH; Messner HA; Schuh AC; Wells RA; Minden MD
    Leuk Res; 2005 Jan; 29(1):113-4. PubMed ID: 15541484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.